Navigation Links
Some Patients Paying for Their Prostate Cancer Surgery for the Rest of Their Lives
Date:9/19/2011

ntionally to stay the course with the radical approach," said Vorstman. "The common post-operative complications associated with this radical surgical approach are impotence and incontinence (limp and leaking)—complications that result in a significant negative impact on QoL not only for the man, but his wife and their partnership."

Dr. Vorstman contends that surgeons eventually recognized this disposition for complications after surgical removal of the prostate, and refined their radical approach to prostate cancer treatment and developed the "nerve sparing" technique in attempts to lessen this propensity for "limp and leaking."

However, he said, this "nerve sparing" approach for prostate cancer excision did not realize the expected great improvement in results with better preservation of erectile function and urinary continence.

This dilemma, according to Dr. Vorstman, then led some surgeons to create "new" definitions for impotence and incontinence so that their radical surgery was now associated with acceptable levels of these complications.

Subsequently, when the biotech industry found a use for their robotic machines in prostate cancer treatment, technology firms soon discovered that they could report even more impressive post operative results.

"These impressive treatment results for radical surgery/robotics were achieved through the coupling of these spurious definitions for limp and leaking with more misleading information," he contends. "This so called data for the non FDA trialed treatment option was then spiced with unbridled and unabashed marketing and propelled into the forefront of prostate cancer treatment as some quasi gold standard."

In an extensive article http://www.hifurx.com/prostate-cancer/prostate-cancer-after-effects/ Dr. Vorstman details "The Good, The Bad and the Ugly" story behind prostate cancer and the in
'/>"/>

SOURCE Dr. Bert Vorstman
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. New Study Finds Cord Blood-derived Stem Cell Treatments Improve Ataxia Patients Functionality and Quality of Life
2. Crucial Directives Must be Revised to Protect Patients Interests and Improve Access to Treatment
3. Biocept and Clarient Announce Collaboration on First Test for Circulating Tumor Cells and HER2 Status in Breast Cancer Patients
4. Stem cell study offers hope for Parkinsons patients
5. BioMarin Initiates Phase 1 Trial for BMN 673 in Patients With Advanced Hematological Malignancies
6. Chimerix Commences Phase 2 Clinical Study of CMX001 for Prevention of Adenovirus Disease in Pediatric and Adult Hematopoietic Stem Cell Transplant Patients
7. RegenoCELL Announces That Patients Can Be Treated With Its Autologous Stem Cell Therapy in Greece
8. Analysis Provides New Insights Into Use of SYMLIN® in Patients With Type 1 Diabetes Using Insulin Pumps
9. Pixantrone in Combination with Fludarabine, Dexamethasone and Rituximab Produces High Rates of Complete Remissions in Patients with Relapsed or Refractory Indolent Non-Hodgkins Lymphoma
10. ACT Announces First Patients Enrolled in Two Clinical Trials Using Embryonic Stem Cells to Treat Stargardts Disease and Dry Age-Related Macular Degeneration
11. Telik Announces Initiation of a Phase 2 Clinical Trial of Telintra® (Ezatiostat HCl) in Patients With Revlimid® Refractory or Resistant Deletion 5q Myelodysplastic Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013   Oligomerix, Inc. ... of disease modifying therapeutics for Alzheimer,s disease (AD) ... of its Series B financing, which includes both ... that would represent approximately $2.8M in new investments ... investors supported the raise. Funding ...
(Date:5/22/2013)... 2013 Genedata, a leading provider ... discovery, and life science research, today announced AB ... as its bioinformatics platform for strain genome data ... provide AB Enzymes, one of the world’s oldest ... of Genedata Selector accompanied by bioinformatics consulting services. ...
(Date:5/22/2013)... MN (PRWEB) May 22, 2013 ... Medical Supplies Pty Ltd are pleased to announce ... is the Australian and New Zealand distributor of DrugCheck® ... V8 Supercar Team participated in the Austin 400 May ... entered into an agreement that involves each car of ...
(Date:5/22/2013)... The ability to sequence genomes has ... encode. There are now a suite of applications ... protected fragments) that dramatically expand our ability to ... Dr. Jonathan Weissman, an Investigator with the University ... Institute, who will present recent applications of their ...
Breaking Biology Technology:Oligomerix, Inc. Completes Series B Financing 2Oligomerix, Inc. Completes Series B Financing 3AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 3AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 4Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2Monitoring Protein Synthesis One Codon at a Time Through Ribosome Profiling, a Webinar Hosted by Xtalks 2
... In a strategic effort to refocus and strengthen ... a regimen of planning to make adjustments in the ... The announcement is made by Denise Brown, FRA Interim ... involves augmenting our board of directors with four of ...
... DermTech, a biotechnology company developing non-invasive molecular diagnostics ... from a study showing that its novel melanoma ... qRT-PCR platform.  Strong earlier results using microarrays have ... discriminated melanoma with 100% sensitivity and 85% specificity. ...
... Inc. (NYSE Amex: PTN ), a biopharmaceutical ... of diseases with significant unmet medical need and commercial ... September 30, 2011. Palatin reported a net loss of ... for the quarter ended September 30, 2011, compared to ...
Cached Biology Technology:Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors 2DermTech's Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study 2DermTech's Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study 3Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011 2Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011 3Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011 4Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011 5
(Date:5/21/2013)... Researchers at the University of Illinois at Chicago College of ... and stores fat -- its main energy source -- and ... disease, under a new $2 million, 4-year grant from the ... heart changes how it uses fuel for energy. These changes ... disease and are different in men and women, says E. ...
(Date:5/21/2013)... Chemical Society (ACS), the world,s largest scientific society, ... Meeting & Exposition, September 8-12, 2013, in Indianapolis, ... Convention Center and at area hotels. , With ... span science,s horizons from astronomy to zoology ... online journalists a rich assortment of spot news ...
(Date:5/21/2013)... , Where? Copenhagen, Denmark: Bella Center ... 2013 , Why? An annual ... policy developments, manufacturing and installation, drawing on leading experiences ... 2013 edition from a record of more than 900 ... 240 plenary and oral presentations, more than 460 visual ...
Breaking Biology News(10 mins):Do men's and women's hearts burn fuel differently? 221st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4
... dozen licensed inventions that will someday enable people to lead ... to NJIT Professor Gordon A. Thomas. Last week Thomas ... engineers to be honored by the New Jersey Inventors Hall ... for his inventions, but also his years of research to ...
... 7, 2011 ID World 2011, the International ... has presented its ID People Trail Blazer Award to Peter ... The award was announced at the 2011 ID World International ... Boyer de la Giroday. The Trail Blazer Award honors pioneering ...
... and physics aims to understand the cell and how ... very complicated. LMU biophysicist Professor Erwin Frey, who is ... Initiative Munich" (NIM) is working with his group on ... professor for statistical and biological physics and his team, ...
Cached Biology News:NJIT physicist receives Innovators Award for tonometer and more 2Peter Went Wins ID People's Trail Blazer Awards 2Attention! End of traffic jam! 2
Recombinant Human HGF...
Human alpha-1-antitrypsin. No cross-reactivity with alpha-1-acid glycoprotein, serum albumin or other serum proteins....
... to histochemically detect specific ... pH in cultured cells ... specific marker is only ... (not found in presenescent/quiescent/immortal ...
Recombinant Mouse LIGHT/TNFSF14...
Biology Products: